BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30061250)

  • 1. Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and Outcomes.
    Buergy D; Rabe L; Siebenlist K; Stieler F; Fleckenstein J; Giordano FA; Wenz F; Boda-Heggemann J
    Anticancer Res; 2018 Aug; 38(8):4789-4796. PubMed ID: 30061250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience.
    Casamassima F; Livi L; Masciullo S; Menichelli C; Masi L; Meattini I; Bonucci I; Agresti B; Simontacchi G; Doro R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):919-23. PubMed ID: 21300473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
    Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
    Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for treatment of adrenal metastases.
    Chawla S; Chen Y; Katz AW; Muhs AG; Philip A; Okunieff P; Milano MT
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):71-5. PubMed ID: 19250766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
    Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
    Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
    Facondo G; Vullo G; Valeriani M; Ascolese AM; De Sanctis V; Osti MF
    Cancer Treat Res Commun; 2021; 29():100481. PubMed ID: 34700142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
    Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
    Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
    Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
    Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Dose Escalation Approaches for Stereotactic Body Radiotherapy to Adrenal Oligometastases: A Single-Institution Experience.
    Figura NB; Oliver DE; Mohammadi H; Martinez K; Grass GD; Hoffe SE; Johnstone PAS; Frakes JM
    Am J Clin Oncol; 2020 Feb; 43(2):107-114. PubMed ID: 31764023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
    Franzese C; Stefanini S; Massaro M; Comito T; Navarria P; Clerici E; Teriaca A; Franceschini D; Reggiori G; Tomatis S; Lania A; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3619-3625. PubMed ID: 34537907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypofractionated stereotactic body radiation therapy for adrenal metastases].
    Dupic G; Biau J; Bellière-Calandry A; Lapeyre M
    Cancer Radiother; 2017 Aug; 21(5):404-410. PubMed ID: 28684242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy for curative treatment of adrenal metastases.
    Rudra S; Malik R; Ranck MC; Farrey K; Golden DW; Hasselle MD; Weichselbaum RR; Salama JK
    Technol Cancer Res Treat; 2013 Jun; 12(3):217-24. PubMed ID: 23369155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
    Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer.
    Celik E; Semrau R; Baues C; Trommer-Nestler M; Baus W; Marnitz S
    Anticancer Res; 2017 Sep; 37(9):5285-5291. PubMed ID: 28870966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.
    Torok J; Wegner RE; Burton SA; Heron DE
    Future Oncol; 2011 Jan; 7(1):145-51. PubMed ID: 21174545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation Therapy in the Management of Adrenal Metastases.
    Franzese C; Stefanini S; Scorsetti M
    Semin Radiat Oncol; 2023 Apr; 33(2):193-202. PubMed ID: 36990636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.